BioMarin Reports First Quarter 2026 Financial and Operating Results
Go back to BioMarin Reports First Quarter 2026 Financial and Operating Results| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 55.59 +0.90 (1.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.69 | 52 Week High | $108.96 | |||
| Open | $55.51 | 52 Week Low | $62.12 | |||
| Day High | $55.87 | P/E | N/A | |||
| Day Low | $54.96 | EPS | $-1.27 | |||
| Volume | 751,124 | |||||
